Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Review(3)
Área de conocimiento
Dolor(1)
Inmunología(1)
Psicopatología(1)
Salud mental(1)
Trastorno depresivo mayor(1)
Origen
scopus(3)
Depression as an immunometabolic disorder: Exploring shared pharma-cotherapeutics with cardiovascular disease
ReviewAbstract: Modern times have seen depression and cardiovascular disease (CVD) become notorious public health coPalabras claves:Cardiovascular disease, Chronic inflammation, Depression, Insulin Resistance, metabolism, Oxidative StressAutores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusPsycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy
ReviewAbstract: The placebo effect can be defined as the improvement of symptoms in a patient after the administratiPalabras claves:Analgesia, Cannabinoids, Conditioning, Depression, hormones, Opioid, Pain, Parkinson’s Disease, placebo effect, PsychoneuroimmunologyAutores:Ariza D., Chávez-Castillo M., Díaz-Camargo E.A., Galbán N., Medina-Ortiz O., Nava M., Ortega A., Riaño-Garzón M.E., Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopus